We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

1 hedge funds and large institutions have $66K invested in Medicines Co in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 278 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 284 → 1 (-283)

100% less funds holding in top 10

Funds holding in top 10: 38 → 0 (-38)

100% less capital invested

Capital invested by funds: $8.36B → $66K (-$8.36B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 278

Holders
1
Holders Change
-283
Holders Change %
-99.65%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-38
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
278
Calls
$12.9M
Puts
–
Net Calls
+$12.9M
Net Calls Change
-$160M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.03B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$648M
3
SCM
Sarissa Capital Management
Connecticut
-$357M
4
HI
HBK Investments
Texas
-$330M
5
FCM
Farallon Capital Management
California
-$282M
Name Holding Trade Value Shares
Change 		Change in
Stake
GT
1
Glenmede Trust
Pennsylvania
$66K – – –
BlackRock
2
BlackRock
New York
– -$1.03B -12,101,435 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$648M -7,632,116 Closed
SCM
4
Sarissa Capital Management
Connecticut
– -$357M -4,202,000 Closed
HI
5
HBK Investments
Texas
– -$330M -3,880,000 Closed
FCM
6
Farallon Capital Management
California
– -$282M -3,315,000 Closed
State Street
7
State Street
Massachusetts
– -$262M -3,085,089 Closed
CS
8
Credit Suisse
Switzerland
– -$245M -2,884,978 Closed
Citigroup
9
Citigroup
New York
– -$216M -2,541,983 Closed
OP
10
Omni Partners
United Kingdom
– -$196K -2,311,536 Closed
MC
11
Maverick Capital
Texas
– -$185M -2,176,487 Closed
MF
12
Magnetar Financial
Illinois
– -$161M -1,892,832 Closed
AAM
13
Alpine Associates Management
Florida
– -$135M -1,590,435 Closed
AA
14
AQR Arbitrage
Connecticut
– -$130M -1,528,417 Closed
IAM
15
Iridian Asset Management
Connecticut
– -$123M -1,448,662 Closed
Westfield Capital Management
16
Westfield Capital Management
Massachusetts
– -$116M -1,368,720 Closed
Wells Fargo
17
Wells Fargo
California
– -$111M -1,301,226 Closed
Millennium Management
18
Millennium Management
New York
– -$110M -1,291,001 Closed
UBS Group
19
UBS Group
Switzerland
– -$108M -1,277,342 Closed
Bank of America
20
Bank of America
North Carolina
– -$104M -1,220,832 Closed
DLPIC
21
Davide Leone & Partners Investment Company
United Kingdom
– -$97.4M -1,146,192 Closed
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
– -$92M -1,082,774 Closed
Morgan Stanley
23
Morgan Stanley
New York
– -$89.8M -1,057,383 Closed
Geode Capital Management
24
Geode Capital Management
Massachusetts
– -$89.3M -1,050,757 Closed
Goldman Sachs
25
Goldman Sachs
New York
– -$83.8M -986,518 Closed
1
2 3 4 5

MDCO Hedge Fund Activity: Q1 2020 in Review

1 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q1 2020, worth a combined $66K — down 100% from $8.36B a quarter earlier.

Sellers outnumbered buyers: 278 funds closed out of MDCO and 0 opened new positions — a net loss of 278 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $1.03B sold.

  • 1 institutional investor held Medicines Co (MDCO) as of Q1 2020, down from 284 in Q4 2019.
  • Funds reported $66K of Medicines Co stock for Q1 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Medicines Co positions in Q1 2020 and 278 closed out, a net change of -278 holders.
  • The largest Medicines Co seller in Q1 2020 was BlackRock, an estimated $1.03B sold.

Based on aggregated 13F filings for Q1 2020.